We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.82B
AUM Growth
-$17.3M
Cap. Flow
+$5.08M
Cap. Flow %
0.28%
Top 10 Hldgs %
24.3%
Holding
256
New
8
Increased
74
Reduced
146
Closed
13

Top Buys

Rank Stock Value
1
BIRK icon
Birkenstock
BIRK
+$19.8M
2
QDEL icon
QuidelOrtho
QDEL
+$15.6M
3
G icon
Genpact
G
+$11.2M
4
LRN icon
Stride
LRN
+$11.1M
5
SRAD icon
Sportradar
SRAD
+$8.21M

Top Sells

Rank Stock Value
1
TKO icon
TKO Group
TKO
+$21.2M
2
MEDP icon
Medpace
MEDP
+$16.4M
3
INSM icon
Insmed
INSM
+$13.7M
4
WNS
WNS Holdings
WNS
+$7.77M
5
ESTA icon
Establishment Labs
ESTA
+$6.56M

Sector Composition

Rank Sector Weight
1 Healthcare 35.36%
2 Technology 27.54%
3 Industrials 16.55%
4 Consumer Discretionary 7.8%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$5.96B
$52.9M 2.91%
279,627
-14,863
-5% -$2.86M
ARLO icon
2
Arlo Technologies
ARLO
$1.51B
$50M 2.75%
3,576,612
+100,831
+3% +$1.59M
FOLD
3
DELISTED
Amicus Therapeutics
FOLD
$50M 2.75%
3,509,571
+74,854
+2% +$735K
FN icon
4
Fabrinet
FN
$16.9B
$48.5M 2.67%
106,516
-4,434
-4% -$1.93M
ESTA icon
5
Establishment Labs
ESTA
$2.71B
$47.5M 2.61%
651,559
-108,638
-14% -$6.56M
ACIW icon
6
ACI Worldwide
ACIW
$5.88B
$46.9M 2.58%
981,314
-15,251
-2% -$740K
FOUR icon
7
Shift4
FOUR
$3.96B
$41.8M 2.3%
663,788
+79,557
+14% +$5.62M
DFIN icon
8
Donnelley Financial Solutions
DFIN
$1.26B
$35.8M 1.97%
765,939
+6,871
+0.9% +$332K
MEDP icon
9
Medpace
MEDP
$16.5B
$35.1M 1.93%
62,514
-28,895
-32% -$16.4M
AWI icon
10
Armstrong World Industries
AWI
$7.05B
$33.1M 1.82%
172,974
-3,688
-2% -$704K
YOU icon
11
Clear Secure
YOU
$5.36B
$32.1M 1.77%
914,235
-48,015
-5% -$1.64M
ASND icon
12
Ascendis Pharma A/S
ASND
$16.6B
$30.9M 1.7%
145,046
-2,044
-1% -$422K
PBH icon
13
Prestige Consumer Healthcare
PBH
$2.39B
$30.9M 1.7%
500,600
-9,068
-2% -$555K
XPO icon
14
XPO
XPO
$24.4B
$29.8M 1.64%
219,176
-4,418
-2% -$602K
LRN icon
15
Stride
LRN
$3.83B
$27.8M 1.53%
427,783
+122,430
+40% +$11.1M
VRDN icon
16
Viridian Therapeutics
VRDN
$2.18B
$27.5M 1.52%
884,532
+32,869
+4% +$901K
SRAD icon
17
Sportradar
SRAD
$4.34B
$27.1M 1.49%
1,140,417
+341,200
+43% +$8.21M
GTLS
18
DELISTED
Chart Industries
GTLS
$26.5M 1.46%
128,574
-1,953
-1% -$396K
ZD icon
19
Ziff Davis
ZD
$1.93B
$26.2M 1.44%
744,232
-8,970
-1% -$313K
WIX icon
20
WIX.com
WIX
$2.36B
$26M 1.43%
250,084
+48,098
+24% +$5.82M
WEX icon
21
WEX
WEX
$6.07B
$25.9M 1.43%
174,138
+153
+0.1% +$23.1K
KNSA icon
22
Kiniksa Pharmaceuticals
KNSA
$4.89B
$24.6M 1.35%
596,431
+18,609
+3% +$746K
QDEL icon
23
QuidelOrtho
QDEL
$1.15B
$23.8M 1.31%
833,791
+574,877
+222% +$15.6M
SUPN icon
24
Supernus Pharmaceuticals
SUPN
$2.73B
$23.3M 1.28%
467,886
-8,195
-2% -$398K
ITRN icon
25
Ituran Location and Control
ITRN
$1.09B
$22.7M 1.25%
528,164
+34,550
+7% +$1.35M
1
2 3 4 5

Similar funds

WIM
WealthPlan Investment Management Omaha, Nebraska $1.79B AUM 17.59% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return

Rice Hall James & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Rice Hall James & Associates held 256 positions worth $1.82B, down 0.95% from $1.83B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q4 2025 filing shows 8 new, 74 increased, 146 reduced and 13 closed positions. Its largest new stake was Birkenstock: 466,577 shares worth $19.1M. The largest sale was TKO Group, an estimated $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q4 2025 buy was Birkenstock: 466,577 shares worth $19.1M.
  • Rice Hall James & Associates added most to QuidelOrtho in Q4 2025, an estimated $15.6M increase.
  • Rice Hall James & Associates's biggest Q4 2025 reduction was TKO Group, cutting an estimated $21.2M.
  • Rice Hall James & Associates fully exited WNS Holdings in Q4 2025, selling an estimated $7.77M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.82B portfolio in Q4 2025.
  • Rice Hall James & Associates opened 8 new positions and closed 13 in Q4 2025.
  • Rice Hall James & Associates's portfolio value fell 0.95% quarter-over-quarter to $1.82B.

Based on Rice Hall James & Associates's 13F filing for Q4 2025, filed 17 Feb 2026.